Comments

Intra-Cellular Therapies

ITCINASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$75.55
0.851.14%
Last update: 11:19 AM
15 minutes delayed
Intra-Cellular Therapies (ITCI) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

Intra-Cellular Therapies (NASDAQ:ITCI) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Intra-Cellular Therapies (ITCI)?

A

There have been no specific sales or earnings guidance reported for Intra-Cellular Therapies in recent months.

Browse guidance and forecast on all stocks.

People Also Watch